If your weight loss goals have taken a backward step, this simple device might be all you need to get back on track and shed ...

The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...

The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

Mounjaro (tirzepatide) is a prescription drug used ... Mounjaro comes as a liquid solution in a single-use prefilled pen. You’ll inject Mounjaro under your skin once weekly.

In the US, tirzepatide is sold as Mounjaro for diabetes and under the Zepbound brand for overweight and obesity and is currently available in the original singe-dose pen-injector format.

"Payments by Pfizer hold the potential to induce specific actions of the prescribing pen." Both Lilly and Pfizer claim their programmes tap into the increased willingness of patients to use ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...

On December 19, 2024, FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly is tirzepatide’s patentholder and the ...

After hours: January 28 at 5:05:00 PM EST Loading Chart for PEN ...

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...

She’s racing to a run-through for a 14-course tasting menu she will barely nibble at as she raves about her weight loss on ...